Company Search:
Advanced Search
Sponsored Links
Peptron Inc Company Snapshot
Peptron Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Peptron Inc with three other pharmaceutical manufacturers in Asia: Syncore Biotechnology Co Ltd of TAIWAN (2019 sales of 12.97 million Taiwanese Dollars [US$446,713.15 ] of which 100% was New drug development), Ever Supreme Bio Technology Co Ltd of TAIWAN (10.82 million Taiwanese Dollars [US$372,714.55 ] of which 100% was Pharmaceutical), and Ensol Biosciences Inc (469.90 million Korean Won [US$404,115.97 ] of which 100% was Pharmaceutical Development and Sales).

Sales Analysis. During the year ended December of 2019, sales at Peptron Inc were 1.80 billion Korean Won (US$1.55 million). This is a sharp decrease of 53.4% versus 2018, when the company's sales were 3.86 billion Korean Won . Contributing to the drop in overall sales was the 83.2% decline in Technology, from 624.53 million Korean Won to 104.83 million Korean Won . There were also decreases in sales in Finished Goods (down 8.2% to 1.70 billion Korean Won ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Peptron Inc
  Stock Performance Chart for Peptron Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 23,800
(Figures in Korean Won )
1 Week -2.5%   13 Weeks 29.3%  
4 Weeks 7.2%   52 Weeks 88.1%  
Peptron Inc Key Data:
  Ticker: 087010 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 1,801,118,527
(Year Ending Jan 2020).
Employees: 82
  Currency: Korean Won Market Cap: 364,770,700,000
  Fiscal Yr Ends: December Shares Outstanding: 15,326,500
  Share Type: Common Closely Held Shares: 1,740,862
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.